Development of a Low-Cost, High-Performance γ‑Oryzanol Nanoparticle–Enriched Feed to Improve Production Efficiency through Gut Microbiota Modulation in Farmed Fish and Achieve Disease-Free Aquaculture
代表機関名 SENTAN Pharma Co., Ltd.
採択年度 2023
フェーズ Previously Selected
Although γ‑oryzanol has an established track record as a functional additive in aquaculture feeds for its antioxidant and immune-enhancing effects, its widespread use has been limited by cost constraints. Using our proprietary technology, we nano-formulate γ‑oryzanol, dramatically enhancing its bioavailability. This enables a substantial reduction in inclusion levels, resulting in significant cost reduction.
Furthermore, γ‑oryzanol nanoparticles improve the gut microbiota of farmed fish, suppressing infectious diseases and thereby enhancing production efficiency in aquaculture.
